That is necessary, because the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work. To put it simply, we need to know how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (united states). However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're created to do. This was an advancement nearly nobody saw. However it's going to have extensive implications for treating disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be lots of financial investment opportunities in this area, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech picks). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it drew back perhaps significantly before going greater - jeff brown stock predictions. I've been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mostly informing readers. But that's not the huge concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So think about that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. jeff bezos. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of great private companies on the edge of hitting the public markets And I have actually been dealing with a new way for you to invest even before these companies go public.
This chance has been building over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the information. Go right here to schedule your area for free.
Emma Walsh here, handling editor of the Diary. Routine Diary readers understand that tech isn't our typical beat (jeff brown prediction for 2021). And when it concerns tech investing, we leave it to the experts. Thankfully, we have several such professionals in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing specialists we know (biotech stocks). In fact, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and far more. These trends are experiencing exponential development and producing unbelievable chances for financiers. I desire to make certain all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. bleeding edge. However regardless of what many readers might think, this is a trend that's simply starting. Even though the COVID-19 pandemic interfered with supply chains in 2015, a remarkable 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown prediction for 2021). Losing 2 months of production and sales actually affects how lots of 5G gadgets are offered in the calendar year. When you consider all of that, selling 250 million systems is amazing. More notably, the delays brought on by the pandemic created a lots of bottled-up demand. Which need is now going to be pushed into 2021. In fact, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - angel investor. And that's not my only 5G forecast When I've spoken about 5G in the past, I've explained its 3 different phases.
In Phase 2, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Phase 3, 5G services begin to be provided (what is the legacy report predicting). That's when we start to see applications running on 5G networks. Think of things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Stage Three by this summertime. This begins something of a virtuous cycle: Many people do not truly appreciate the technology. However they will care if there are exciting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In truth, 5G is going to open a suite of unbelievable applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these technologies require 5G. The investment opportunities going forward will be massive. Stepping away from 5G, the next important innovation I predict in 2021 is CRISPR genetic editing. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it's one of the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not function properly. CRISPR utilizes a similar idea however with our genetic code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well comprehended. And during that time, there were actually just three business running in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this innovation just works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and providing amazing returns. This entire market is successfully a greenfield opportunity.
There's space for lots of companies to exist in this area. exponential tech investor. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or 3 more genetic editing business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software application can properly anticipate the folding of a protein based solely on its amino acid series with 92. 4% accuracy. That is very important due to the fact that the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error process. And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug therapies produced utilizing this innovation. This was one of those advancements that almost no one saw. However it's going to have extensive ramifications for curing illness. And, of course, there will be plenty of investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back possibly considerably before going higher. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin - future report review. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. But at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. self-driving cars. Mass, Mutual is a 150-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the info depends on date since February 2021, however we could not individually validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to choose winning innovation stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an excellent perspective on the market. He's always on the hunt for new opportunities, and he shares a number of his best choices in the Near Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he successfully anticipated a few of the biggest economic events of the past twenty years. Although he doesn't appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it right whenever, however Jeff Brown's precise forecasts have earned him legions of dedicated followers. That states a lot about his capability. The Near Future Report is published by Brownstone Research study, a prominent monetary research study publisher. Brownstone Research study offers several research study services with a wide array of expertises - angel investor.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - jeff brown. On its site, Brownstone states its mission is to provide retail investors with professional-grade research study: "For too long, the very best investment research has not been readily available to individual financiers. It has actually been typically booked for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown market predictions. The objective of Brownstone Research study is to make that sort of proprietary research study readily available to any financiers looking to get an edge in the markets. The objective is simple to deliver unique and lucrative investment research study discovered nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise serves as the firm's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After years of constant success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout the majority of America. If you understand even a bit about the market, you understand that he has a reputation as a King Midas of sorts. jeff bezos. Everything he touches turns to gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In fact, Brown thinks S.A.V. jeff brown top biotech 2020. might be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding two innovative technologies: expert system and electrical cars. Musk hopes the combination will help him develop the very first fully-autonomous, self-driving cars ever. It's nothing except the automobile market's Holy Grail. As you know, electric cars and self-driving automobile stocks have been huge this year, but the Wall Street maker has actually approved buzz without much concrete outcome. Despite an extreme boost in competitors over the past couple of years, Brown still believes Musk has the very best chance of putting it all together.
tech might be the magic string that ties it all together. S.A.V. means Shared Autonomous Vehicle, and it might be the future of transportation. Generally, this innovation would enable you to lease your cars and truck as a self-governing, self-driving taxi when you're not utilizing it. You simply leave the car and press a button on an app that informs the automobile to "sign up with the fleet." Next thing you understand, you're unwinding on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a hefty piece of the earnings. It sounds ridiculous, but it could be closed than you think.